Affiliations

NYBA

Australia Biotech

BioMelbourne

Lab To Wall Street

Industry News

Browse news archive by:
Date | Company Name | Country/States

Dec. Nov. Oct. Sept. Aug. July
June May April March Feb. Jan.

November 2007:

November 26th:
HealthLinx In-licenses New Technology To Develop Second Generation Ovarian Cancer Diagnostic Targeting Early Stage Disease
read article >

November 19th:
Bone Receives Notice of Allowance for Axcess I Patent in US Important First Patent Securing Future Developments
read article >

November 14th:
Progen To Conduct Global Search For New Directors
read article >

November 5th:
Pharmaxis Completes US FDA Special Protocol Assessment
read article >

November 5th:
Aridol To Be Evaluated In Major US Study
read article >

November 5th:
Key Porcine Adenoviral Delivery Vector Patent To Be Granted In China
read article >

  May 28th, 2009:
Arana Therapeutics Board Changes

May 6th, 2009:
Circadian Scientific Advisory Board Chairman, Professor Kari Alitalo, Wins Prestigious Award for Biomedical Research

May 5th, 2009:
Living Cell Technologies Reports Insulin Independence in Two Patients Following Recent Implants of DIABECELL® in Diabetes Clinical Trial

November 3rd:
FDA Accepts Arana's Anti-inflammatory IND

September 4th:
Cytopia Commences Second Phase II Study in Brain Cancer

September 4th:
Pharmaxis Announces Second Pivotal Phase 3 Trial in Cystic Fibrosis Begins

August 6th:
Xenome Strengthens Board with Two New Appointments

August 6th:
Ciba Elects to Cease Industrial Product Evaluations

June 24th:
New Pharmaxis Board Appointment

April 29th:
Benitec secures further rights to HIV Therapeutic

more industry news >
 


osullivanpllc.com  

Disclaimer